 | • レポートコード：MRC2102QY1757 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の良性前立腺肥大症用デバイス市場について種類別（経尿道的前立腺切除術（TURP）、経尿道的マイクロ波療法（TUMT）、経尿道的前立腺切除術（TUNA）、レーザー手術、前立腺ステント留置術、その他）、用途別（病院・診療所、外来手術センター（ASC）、家庭用、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・良性前立腺肥大症用デバイス市場の概要 ・世界の主要地域別良性前立腺肥大症用デバイス市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の良性前立腺肥大症用デバイス市場規模2015-2026：種類別（経尿道的前立腺切除術（TURP）、経尿道的マイクロ波療法（TUMT）、経尿道的前立腺切除術（TUNA）、レーザー手術、前立腺ステント留置術、その他） ・世界の良性前立腺肥大症用デバイス市場規模2015-2026：用途別（病院・診療所、外来手術センター（ASC）、家庭用、その他） ・良性前立腺肥大症用デバイスの米国市場規模2015-2020 ・良性前立腺肥大症用デバイスのヨーロッパ市場規模2015-2020 ・良性前立腺肥大症用デバイスの中国市場規模2015-2020 ・良性前立腺肥大症用デバイスの日本市場規模2015-2020 ・良性前立腺肥大症用デバイスの東南アジア市場規模2015-2020 ・良性前立腺肥大症用デバイスのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・良性前立腺肥大症用デバイスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・良性前立腺肥大症用デバイスの市場動向・機会・課題 ・調査の結論 |
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Market Analysis and Insights: Global Benign Prostatic Hyperplasia Devices Market
The global Benign Prostatic Hyperplasia Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Benign Prostatic Hyperplasia Devices Scope and Market Size
The global Benign Prostatic Hyperplasia Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Benign Prostatic Hyperplasia Devices market is segmented into
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Segment by Application, the Benign Prostatic Hyperplasia Devices market is segmented into
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
The Benign Prostatic Hyperplasia Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Benign Prostatic Hyperplasia Devices market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Benign Prostatic Hyperplasia Devices Market Share Analysis
Benign Prostatic Hyperplasia Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Benign Prostatic Hyperplasia Devices business, the date to enter into the Benign Prostatic Hyperplasia Devices market, Benign Prostatic Hyperplasia Devices product introduction, recent developments, etc.
The major vendors covered:
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
1 Benign Prostatic Hyperplasia Devices Market Overview
1.1 Benign Prostatic Hyperplasia Devices Product Scope
1.2 Benign Prostatic Hyperplasia Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia Devices Sales by Type (2020-2026)
1.2.2 Transurethral Resection of the Prostate (TURP)
1.2.3 Transurethral Microwave Therapy (TUMT)
1.2.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.5 Laser Surgery
1.2.6 Prostatic Stenting
1.2.7 Others
1.3 Benign Prostatic Hyperplasia Devices Segment by Application
1.3.1 Global Benign Prostatic Hyperplasia Devices Sales Comparison by Application (2020-2026)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Benign Prostatic Hyperplasia Devices Sales Growth Rate (2015-2026)
1.4.2 Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Benign Prostatic Hyperplasia Devices Price Trends (2015-2026)
2 Benign Prostatic Hyperplasia Devices Estimate and Forecast by Region
2.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Benign Prostatic Hyperplasia Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2015-2020)
2.3 Global Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Benign Prostatic Hyperplasia Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
2.4.2 Europe Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
2.4.3 China Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
2.4.4 Japan Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
2.4.6 India Benign Prostatic Hyperplasia Devices Estimates and Projections (2015-2026)
3 Global Benign Prostatic Hyperplasia Devices Competition Landscape by Players
3.1 Global Top Benign Prostatic Hyperplasia Devices Players by Sales (2015-2020)
3.2 Global Top Benign Prostatic Hyperplasia Devices Players by Revenue (2015-2020)
3.3 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Devices as of 2019)
3.4 Global Benign Prostatic Hyperplasia Devices Average Price by Company (2015-2020)
3.5 Manufacturers Benign Prostatic Hyperplasia Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Benign Prostatic Hyperplasia Devices Players (Opinion Leaders)
4 Global Benign Prostatic Hyperplasia Devices Market Size by Type
4.1 Global Benign Prostatic Hyperplasia Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Benign Prostatic Hyperplasia Devices Price by Type (2015-2020)
4.2 Global Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Benign Prostatic Hyperplasia Devices Price Forecast by Type (2021-2026)
5 Global Benign Prostatic Hyperplasia Devices Market Size by Application
5.1 Global Benign Prostatic Hyperplasia Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Benign Prostatic Hyperplasia Devices Price by Application (2015-2020)
5.2 Global Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Benign Prostatic Hyperplasia Devices Price Forecast by Application (2021-2026)
6 United States Benign Prostatic Hyperplasia Devices Market Facts & Figures
6.1 United States Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
6.2 United States Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
6.3 United States Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
7 Europe Benign Prostatic Hyperplasia Devices Market Facts & Figures
7.1 Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
7.2 Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
7.3 Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
8 China Benign Prostatic Hyperplasia Devices Market Facts & Figures
8.1 China Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
8.2 China Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
8.3 China Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
9 Japan Benign Prostatic Hyperplasia Devices Market Facts & Figures
9.1 Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Company (3015-3030)
9.2 Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
9.3 Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
10 Southeast Asia Benign Prostatic Hyperplasia Devices Market Facts & Figures
10.1 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
11 India Benign Prostatic Hyperplasia Devices Market Facts & Figures
11.1 India Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
11.2 India Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
11.3 India Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Benign Prostatic Hyperplasia Devices Business
12.1 Lumenis
12.1.1 Lumenis Corporation Information
12.1.2 Lumenis Business Overview
12.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Lumenis Benign Prostatic Hyperplasia Devices Products Offered
12.1.5 Lumenis Recent Development
12.2 Olympus corporation
12.2.1 Olympus corporation Corporation Information
12.2.2 Olympus corporation Business Overview
12.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Products Offered
12.2.5 Olympus corporation Recent Development
12.3 Urologix
12.3.1 Urologix Corporation Information
12.3.2 Urologix Business Overview
12.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Urologix Benign Prostatic Hyperplasia Devices Products Offered
12.3.5 Urologix Recent Development
12.4 Boston Scientific corporation
12.4.1 Boston Scientific corporation Corporation Information
12.4.2 Boston Scientific corporation Business Overview
12.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Products Offered
12.4.5 Boston Scientific corporation Recent Development
12.5 Lisa Laser
12.5.1 Lisa Laser Corporation Information
12.5.2 Lisa Laser Business Overview
12.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Products Offered
12.5.5 Lisa Laser Recent Development
12.6 Medifocus
12.6.1 Medifocus Corporation Information
12.6.2 Medifocus Business Overview
12.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Medifocus Benign Prostatic Hyperplasia Devices Products Offered
12.6.5 Medifocus Recent Development
12.7 Neotrac
12.7.1 Neotrac Corporation Information
12.7.2 Neotrac Business Overview
12.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Neotrac Benign Prostatic Hyperplasia Devices Products Offered
12.7.5 Neotrac Recent Development
12.8 ProArc Medical LTD
12.8.1 ProArc Medical LTD Corporation Information
12.8.2 ProArc Medical LTD Business Overview
12.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Products Offered
12.8.5 ProArc Medical LTD Recent Development
12.9 Urotech GMBH
12.9.1 Urotech GMBH Corporation Information
12.9.2 Urotech GMBH Business Overview
12.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Products Offered
12.9.5 Urotech GMBH Recent Development
13 Benign Prostatic Hyperplasia Devices Manufacturing Cost Analysis
13.1 Benign Prostatic Hyperplasia Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
13.4 Benign Prostatic Hyperplasia Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Benign Prostatic Hyperplasia Devices Distributors List
14.3 Benign Prostatic Hyperplasia Devices Customers
15 Market Dynamics
15.1 Benign Prostatic Hyperplasia Devices Market Trends
15.2 Benign Prostatic Hyperplasia Devices Opportunities and Drivers
15.3 Benign Prostatic Hyperplasia Devices Market Challenges
15.4 Benign Prostatic Hyperplasia Devices Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Benign Prostatic Hyperplasia Devices Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Benign Prostatic Hyperplasia Devices Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Benign Prostatic Hyperplasia Devices Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Region (2015-2020)
Table 5. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2015-2020)
Table 6. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Benign Prostatic Hyperplasia Devices Revenue Share by Region (2015-2020)
Table 8. Global Benign Prostatic Hyperplasia Devices Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Benign Prostatic Hyperplasia Devices Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Benign Prostatic Hyperplasia Devices Revenue Share Forecast by Region (2021-2026)
Table 12. Global Benign Prostatic Hyperplasia Devices (K Units) of Key Companies (2015-2020)
Table 13. Global Benign Prostatic Hyperplasia Devices Sales Share by Company (2015-2020)
Table 14. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Benign Prostatic Hyperplasia Devices Revenue Share by Company (2015-2020)
Table 16. Global Benign Prostatic Hyperplasia Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Devices as of 2019)
Table 17. Global Benign Prostatic Hyperplasia Devices Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Benign Prostatic Hyperplasia Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Benign Prostatic Hyperplasia Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Benign Prostatic Hyperplasia Devices Players
Table 22. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 23. Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2015-2020)
Table 24. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Benign Prostatic Hyperplasia Devices Price (K Units) by Type (2015-2020)
Table 26. Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2021-2026)
Table 27. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2021-2026)
Table 29. Global Benign Prostatic Hyperplasia Devices Price (K Units) by Type (2021-2026)
Table 30. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 31. Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2015-2020)
Table 32. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Benign Prostatic Hyperplasia Devices Price (K Units) by Application (2015-2020)
Table 34. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2021-2026)
Table 35. Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2021-2026)
Table 36. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Benign Prostatic Hyperplasia Devices Revenue Share by Application (2021-2026)
Table 38. Global Benign Prostatic Hyperplasia Devices Price (K Units) by Application (2021-2026)
Table 39. United States Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 40. United States Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 41. United States Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 42. United States Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 43. United States Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 44. United States Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
Table 45. Europe Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 46. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 47. Europe Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 48. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 49. Europe Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 50. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 51. China Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 52. China Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 53. China Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 54. China Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 55. China Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 56. China Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
Table 57. Japan Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 58. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 59. Japan Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 60. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 61. Japan Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 62. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
Table 69. India Benign Prostatic Hyperplasia Devices Sales (K Units) by Company (2015-2020)
Table 70. India Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2015-2020)
Table 71. India Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2015-2020)
Table 72. India Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2015-2020)
Table 73. India Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2015-2020)
Table 74. India Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2015-2020)
Table 75. Lumenis Corporation Information
Table 76. Lumenis Description and Business Overview
Table 77. Lumenis Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Lumenis Benign Prostatic Hyperplasia Devices Product
Table 79. Lumenis Recent Development
Table 80. Olympus corporation Corporation Information
Table 81. Olympus corporation Description and Business Overview
Table 82. Olympus corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Olympus corporation Benign Prostatic Hyperplasia Devices Product
Table 84. Olympus corporation Recent Development
Table 85. Urologix Corporation Information
Table 86. Urologix Description and Business Overview
Table 87. Urologix Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Urologix Benign Prostatic Hyperplasia Devices Product
Table 89. Urologix Recent Development
Table 90. Boston Scientific corporation Corporation Information
Table 91. Boston Scientific corporation Description and Business Overview
Table 92. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product
Table 94. Boston Scientific corporation Recent Development
Table 95. Lisa Laser Corporation Information
Table 96. Lisa Laser Description and Business Overview
Table 97. Lisa Laser Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Lisa Laser Benign Prostatic Hyperplasia Devices Product
Table 99. Lisa Laser Recent Development
Table 100. Medifocus Corporation Information
Table 101. Medifocus Description and Business Overview
Table 102. Medifocus Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Medifocus Benign Prostatic Hyperplasia Devices Product
Table 104. Medifocus Recent Development
Table 105. Neotrac Corporation Information
Table 106. Neotrac Description and Business Overview
Table 107. Neotrac Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Neotrac Benign Prostatic Hyperplasia Devices Product
Table 109. Neotrac Recent Development
Table 110. ProArc Medical LTD Corporation Information
Table 111. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. ProArc Medical LTD Description and Business Overview
Table 113. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product
Table 114. ProArc Medical LTD Recent Development
Table 115. Urotech GMBH Corporation Information
Table 116. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Urotech GMBH Description and Business Overview
Table 118. Urotech GMBH Benign Prostatic Hyperplasia Devices Product
Table 119. Urotech GMBH Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Benign Prostatic Hyperplasia Devices Distributors List
Table 123. Benign Prostatic Hyperplasia Devices Customers List
Table 124. Benign Prostatic Hyperplasia Devices Market Key Trends
Table 125. Benign Prostatic Hyperplasia Devices Key Opportunities and Drivers
Table 126. Benign Prostatic Hyperplasia Devices Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Benign Prostatic Hyperplasia Devices Product Picture
Figure 2. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Benign Prostatic Hyperplasia Devices Market Share by Application in 2020 & 2026
Figure 6. Hospitals and Clinics Examples
Figure 7. Ambulatory Surgical Centers(ASC) Examples
Figure 8. Home Examples
Figure 9. Others Examples
Figure 10. Global Benign Prostatic Hyperplasia Devices Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Benign Prostatic Hyperplasia Devices Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Benign Prostatic Hyperplasia Devices Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Benign Prostatic Hyperplasia Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Benign Prostatic Hyperplasia Devices Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Benign Prostatic Hyperplasia Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Benign Prostatic Hyperplasia Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Benign Prostatic Hyperplasia Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Benign Prostatic Hyperplasia Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Benign Prostatic Hyperplasia Devices Players Market Share by Revenue in Benign Prostatic Hyperplasia Devices 2015 & 2019
Figure 28. Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2015-2020)
Figure 30. Global Benign Prostatic Hyperplasia Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Benign Prostatic Hyperplasia Devices Revenue Share by Application (2015-2020)
Figure 32. Global Benign Prostatic Hyperplasia Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 34. United States Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 35. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2019
Figure 36. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 37. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2019
Figure 38. China Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2019
Figure 39. China Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 40. China Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2019
Figure 41. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2019
Figure 42. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 43. Japan Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2019
Figure 44. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2019
Figure 45. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 46. Southeast Asia Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2019
Figure 47. India Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2019
Figure 48. India Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2019
Figure 49. India Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Benign Prostatic Hyperplasia Devices
Figure 52. Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
Figure 53. Benign Prostatic Hyperplasia Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
良性前立腺肥大症（BPH）治療薬の世界市場レポート2020 BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this…- 前立腺生検装置の世界市場レポート2020 Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer. Prostate biopsy samples can be collected in different ways. Your prostate biopsy may involve: 1. Passing the needle through the …
- 前立腺生検針の世界市場レポート2020 Market Analysis and Insights: Global Prostate Biopsy Needle Market The global Prostate Biopsy Needle market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Prostate Biopsy Needle Scope and Market Size The global Prostate Biops…
- ニードルフリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Needle-Free Devices Market The global Needle-Free Devices market size is projected to reach US$ 3836.3 million by 2026, from US$ 2818.5 million in 2020, at a CAGR of 5.3% during 2021-2026. Global Needle-Free Devices Scope and Market Size The global Needle-Free De…
- 疼痛管理用高周波焼灼装置の世界市場レポート2020 Market Analysis and Insights: Global Radiofrequency Ablation Devices for Pain Management Market The global Radiofrequency Ablation Devices for Pain Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Radiofrequen…